Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report
- DOI
- 10.3389/fonc.2023.1330468
- Published
- 2024-01-23
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2023.1330468,
title = {Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report},
author = {Myriam Mirza and Aseem Shrivastava and Cecile Matthews and Natasha Leighl and Calvin S. H. Ng and David Planchard and Sanjay Popat and Julia Rotow and Egbert F. Smit and Ross Soo and Masahiro Tsuboi and Fan Yang and Brendon Stiles and Christian Grohe and Yi-Long Wu},
year = {2024},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2023.1330468},
url = {https://doi.org/10.3389/fonc.2023.1330468}
}RIS
TY - JOUR TI - Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report AU - Myriam Mirza AU - Aseem Shrivastava AU - Cecile Matthews AU - Natasha Leighl AU - Calvin S. H. Ng AU - David Planchard AU - Sanjay Popat AU - Julia Rotow AU - Egbert F. Smit AU - Ross Soo AU - Masahiro Tsuboi AU - Fan Yang AU - Brendon Stiles AU - Christian Grohe AU - Yi-Long Wu PY - 2024 JO - Frontiers in Oncology DO - 10.3389/fonc.2023.1330468 UR - https://doi.org/10.3389/fonc.2023.1330468 ER -
APA
Mirza, M., Shrivastava, A., Matthews, C., Leighl, N., Ng, C. S. H., Planchard, D., Popat, S., Rotow, J., Smit, E. F., Soo, R., Tsuboi, M., Yang, F., Stiles, B., Grohe, C., & Wu, Y. (2024). Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1330468
Source records
- crossref · retrieved 2026-09-26T10:58:00.001Z